|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/426 | |
| A61K 31/427 | |||
| A61K 31/4439 | |||
| A61K 31/506 | |||
| A61K 31/519 | |||
| A61K 31/5377 | |||
| A61K 31/635 | |||
| A61K 45/06 | |||
| A61P 17/02 | |||
| A61K 31/197 | |||
| A61K 31/53 |
| (11) | Patento numeris | 3291811 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16719430.7 |
| Europos patento paraiškos padavimo data | 2016-05-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/059734 |
| Data | 2016-05-02 |
| (87) | Numeris | WO 2016/177660 |
| Data | 2016-11-10 |
| (30) | Numeris | Data | Šalis |
| 15166516 | 2015-05-06 | EP |
| (72) |
HIRTH-DIETRICH, Claudia, DE
SANDNER, Peter, DE
STASCH, Johannes-Peter, IT
HAHN, Michael, DE
FOLLMANN, Markus, DE
VAKALOPOULOS, Alexandros, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (54) | THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC) |
| THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC) |